WHO ICTRP trial
Additional Testosterone treatment in heart failure.
CTRI/2021/01/030292 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/01/030292 |
|---|---|
| Public title | Additional Testosterone treatment in heart failure. |
| Scientific title | Adjuvant testosterone therapy in chronic heart failure - A Randomized Open Label Clinical Trial |
| Primary sponsor | AIIMS Rishikesh |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: I508- Other heart failure |
| Interventions | Intervention1: Testosterone: 5mg testosterone gel+recommended standard therapy for chronic stable heart failure Duration 12 week Route - Transdermal Control Intervention1: Recommended standard therapy chronic stable heart failure… |
| Registration date | Jun 1, 2021 |
| Target size | 160 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: